Development of novel monoclonal antibodies for detection of pan-Lassa virus
PLOS Neglected Tropical Diseases · 11.05.2026 · 20 (5) · e0014326
DOI: 10.1371/journal.pntd.0014326 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 11.05.2026. Verfasst von Ruchi Paroha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Texas Medical Branch, Galveston, Texas, United States of America. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antibodies, Viral, Lassa virus. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Institute for Human Infections and Immunity.
Abstract (Originalsprache)
Lassa virus (LASV), the causative agent of Lassa fever (LF), poses a significant public health concern in endemic regions due to its high morbidity and mortality. Rapid and accurate diagnosis is critical for effective clinical management and containment during LF outbreaks. However, the genetic diversity of LASV, encompassing at least seven distinct lineages, poses a major challenge for the development of broadly reactive diagnostic tools. Therefore, there is an urgent need to develop detection methods that are effective across diverse lineages. To address this challenge, we generated a panel of cross-reactive monoclonal antibodies (mAbs) targeting the LASV nucleoprotein (NP). Several mAbs exhibited broad reactivity across LASV lineages I-VII in different immunoassays such as enzyme-linked immunosorbent assay (ELISA), western blotting, and immunofluorescence assay. Utilizing these broadly reactive mAbs, we developed an antigen-capture sandwich ELISA capable of detecting LASV NP from all seven lineages with high sensitivity. Our findings highlight a set of novel mAbs with broad cross-reactivity across lineage. In addition, we demonstrated their utility in a sandwich ELISA format for pan -LASV detection. This pan -LASV diagnostic approach offers a promising tool for improved LF diagnosis in both clinical and epidemiological settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
- Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, Texas, United States of America.
- Institute for Human Infections and Immunity, The University of Texas Medical Branch, Galveston, Texas, United States of America.
ORCID-Profile: Junki Maruyama
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Institute for Human Infections and Immunity
- John S. Dunn Foundation
Zitieren
APA
Paroha, R., Saito, T., Yamada, S., Click, C., Paessler, S., & Maruyama, J. (2026). Development of novel monoclonal antibodies for detection of pan-Lassa virus. PLOS Neglected Tropical Diseases, 20(5), e0014326. https://doi.org/10.1371/journal.pntd.0014326
Vancouver
Paroha R, Saito T, Yamada S, Click C, Paessler S, Maruyama J. Development of novel monoclonal antibodies for detection of pan-Lassa virus. PLOS Neglected Tropical Diseases. 2026;20(5):e0014326. doi:10.1371/journal.pntd.0014326
BibTeX
@article{Paroha2026,
author = {Paroha, Ruchi and Saito, Takeshi and Yamada, Shintaro and Click, Christine and Paessler, Slobodan and Maruyama, Junki},
title = {Development of novel monoclonal antibodies for detection of pan-Lassa virus},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
volume = {20},
number = {5},
pages = {e0014326},
doi = {10.1371/journal.pntd.0014326}
}
EUVIMED